دورية أكاديمية
Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda
| العنوان: | Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda |
|---|---|
| المؤلفون: | Joseph Kabatende, Lazare Ntirenganya, Michael Mugisha, Abbie Barry, Eugene Ruberanziza, Emile Bienvenu, Ulf Bergman, Eleni Aklillu |
| المصدر: | Pathogens, Vol 12, Iss 9, p 1170 (2023) |
| بيانات النشر: | MDPI AG, 2023. |
| سنة النشر: | 2023 |
| المجموعة: | LCC:Medicine |
| مصطلحات موضوعية: | praziquantel, efficacy, preventive chemotherapy, mass drug administration, school-age children, schistosomiasis, Medicine |
| الوصف: | Preventive chemotherapy with single-dose praziquantel is the WHO-recommended intervention strategy to eliminate schistosomiasis as a public health problem in endemic countries. Surveillance of drugs used in mass drug administration (MDA) programs is recommended to evaluate its effectiveness in reducing transmissions. After a decade-long implementation of a school-based MDA program in Rwanda, we conducted efficacy surveillance of single-dose praziquantel MDA against S. mansoni infection. Two weeks before MDA, stool examinations were performed to screen MDA-eligible school children (n = 4998) for S. mansoni infection using the Kato–Katz technique, and 265 (6.5%) children tested positive for the infection. All children received praziquantel and albendazole as preventive chemotherapy through the MDA campaign. Infected children were enrolled and followed for efficacy monitoring, and stool examination was repeated after three weeks post-MDA (n = 188). Before treatment, 173 (92%) had a light infection, and 15 (8%) had a moderate infection intensity. The primary and secondary outcomes were parasitological cure and egg reduction rates at three weeks post-treatment. The overall cure and egg reduction rates for S. mansoni infection were 97.9% (95% CI = 94.6–99.4) and 97.02%, respectively. Among the 173 children with light infection intensity, 170 (98.3%, 95% CI = 95.0–99.6) were cured, and among the 15 children who had moderate infection intensity, 14 (93.3%) were cured. No significant association between cure rate and pre-treatment infection intensity was observed. We conclude that single-dose praziquantel is efficacious against light-to-moderate S. mansoni infection. Preventive chemotherapy with praziquantel effectively reduces schistosome reservoirs and transmission among school-age children. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 12091170 2076-0817 |
| Relation: | https://www.mdpi.com/2076-0817/12/9/1170; https://doaj.org/toc/2076-0817 |
| DOI: | 10.3390/pathogens12091170 |
| URL الوصول: | https://doaj.org/article/b964df7d78104056b981797f5202ece8 |
| رقم الأكسشن: | edsdoj.b964df7d78104056b981797f5202ece8 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 12091170 20760817 |
|---|---|
| DOI: | 10.3390/pathogens12091170 |